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ABSTRACT
Test parameters and clinical impact of the direct
tube coagulase test (DTCT) for rapid identiﬁca-
tion of Staphylococcus aureus from blood culture
were investigated. The sensitivity of the DTCT at
4 h using saline dilution was 96%, compared with
93% using serum separator tubes; speciﬁcity was
100% for both methods. Among 32 patients with
S. aureus bacteraemia, treatment modiﬁcations
were based on microbiology results from the
primary source of infection in 12 patients, on a
Gram’s stain from blood culture in seven patients,
and on the DTCT in nine patients. The DTCT is a
valuable adjunct in the routine microbiology
laboratory because of its good performance,
technical simplicity and low cost.
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Staphylococcus aureus bacteraemia is a serious
condition with high rates of mortality and
morbidity [1,2]. In contrast, coagulase-negative
staphylococci isolated from blood often represent
skin contaminants, except in certain clinical con-
ditions [3]. Early reporting of blood culture results
can improve antimicrobial management and de-
crease costs [4–6]. In the case of S. aureus bactera-
emia, patient outcome is poorer if appropriate
treatment is delayed [7,8]. Awide range of tests for
the rapid identiﬁcation of S. aureus have been
applied to blood cultures [9–20], but the direct
tube coagulase test (DTCT) has the advantage that
it is easy to perform in any laboratory, rapid,
ﬂexible in daily use, and inexpensive. The present
study investigated the performance of the DTCT,
using two sample preparation methods, and eval-
uated the impact of rapid identiﬁcation of S. aureus
fromblood cultures on antimicrobialmanagement.
In total, 633 blood cultures (BACTEC; Becton
Dickinson, Franklin Lakes, NJ, USA) containing
Gram-positive cocci in clusters upon micro-
scopical examination were received at the micro-
biology laboratory of the University Medical
Centre Nijmegen, The Netherlands, between
October 2005 and March 2006. Blood culture
bottles with growth detected between 14.00 and
17.00 hours on weekdays and between
14.00 hours on Fridays and closure of the labora-
tory on Sundays were excluded from this study,
since readings of the DTCT at 2 and 4 h would fall
outside regular working hours. Blood cultures
collected routinely from patients in the adult
haematology wards or attending the paediatric
oncology outpatient clinic were also excluded
because of the high rate of contaminated cultures
in these settings.
For DTCTs using serum separator tubes (SSTs),
blood culture broth (8.5 mL) from positive blood
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culture bottles yielding Gram-positive cocci in
clusters was collected in SST II Advance tubes
(Becton Dickinson) using a subculture-venting
unit. After centrifugation at 2000 g for 10 min, the
supernatant was discarded and 1 mL of citrate
rabbit plasma was added to the remaining pellet
of bacteria and vortexed brieﬂy. For DTCTs using
saline dilution (SDT), a 1:10 dilution of blood
culture broth in saline was made [20]. After brief
vortexing, four drops (0.1 mL) were added to
1 mL of rabbit plasma. Both tests were evaluated
for clot formation after incubation at 37C for
2 h and 4 h, and, if negative, after overnight
incubation at room temperature. Clot formation
was evaluated independently by a technician
working in the routine laboratory and by two
microbiologists in order to investigate inter-
observer variability.
Isolates were identiﬁed using standard micro-
biological procedures, including Gram’s stain,
colony morphology, slide coagulase and tube
coagulase tests, and the Phoenix Automated
Microbiology System (Becton Dickinson). Results
of Gram’s stains were reported to the responsible
physician by the clinical microbiologist as soon as
they were available. If the DTCT was positive,
using either of the two methods, the physician
was again contacted and informed about the
rapid identiﬁcation methods being investigated;
antimicrobial treatment modiﬁcations based on
the Gram’s stain or DTCT results were at the
physician’s discretion.
In total, 286 blood culture vials collected from
142 patients were included in the study; S. aureus
was isolated from 81 vials (38 aerobic, 35 anaer-
obic and eight paediatric bottles) from 32
patients, and coagulase-negative staphylococci
were isolated from 205 vials from 110 patients.
There was no inter-observer disagreement, and
there was 100% speciﬁcity for both tests. The
sensitivities of the SST and SDT did not differ
signiﬁcantly after 4 h or overnight incubation
(Table 1), but the sensitivity of the SST after 2 h
and 4 h was signiﬁcantly higher with the aerobic
vials than with the anaerobic vials (i.e., 97% and
100% vs. 69% and 83%, respectively; p £0.01,
Fisher’s exact test). While the speciﬁcity of the
DTCT has consistently been reported to be
>99%, reported sensitivities range between 62%
and 100% [9–12,16–18,20]. These variable results
may be caused by the use of blood culture bottles
from different manufacturers, different sample
preparation methods or different incubation
times. A large study using BACTEC bottles
showed a speciﬁcity of 99.7%, but a sensitivity
of only 65%, which was explained by poor
interpretation of clot formation in the routine
laboratory [17]. This low sensitivity is not in
keeping with the results of the present and other
studies that used BACTEC bottles, which
showed sensitivities of 92% and 100% [12,18].
Since neat broth was used in the test, the
carryover of anticoagulants or other substances,
particularly from the anaerobic broth (39.8%
were anaerobic bottles), which seemed to inter-
fere with clot formation in the present study,
may have contributed to this low sensitivity [20].
Clinical diagnosis, antimicrobial treatment and
treatment modiﬁcations, based on the microbiol-
ogy results, are summarised in Table 2. Because
multiple blood culture vials were tested, all
patients with S. aureus bacteraemia yielded posi-
tive results with the DTCT within 4 h. Twenty-
eight (88%) of 32 patients received antimicrobial
therapy with activity against S. aureus before
blood culture results were available. Treatment
modiﬁcations based on blood culture results were
made for 19 (59%) patients. The DTCT contrib-
uted to the management of nine patients; anti-
staphylococcal treatment was initiated in one
patient, and antimicrobial treatment was stream-
lined in eight patients. Based on the Gram’s stain
results from the blood culture, treatment was
initiated in two patients and streamlined in ﬁve
patients. In one patient, treatment was adjusted
only after deﬁnitive identiﬁcation of S. aureus
from the blood culture. The potential contribution
of the DTCT could not be evaluated for two
patients (patients 15 and 20), since empirical
antibiotics were modiﬁed on the basis of a
deﬁnitive identiﬁcation of S. aureus from blood
cultures that became positive during the week-
Table 1. Sensitivity (S), speciﬁcity (SP), positive predictive
value (PPV) and negative predictive value (NPV) of the
direct tube coagulase test (DTCT) using the serum sepa-
rator tube (SST) and saline dilution (SDT) methods
DTCTa S SP PPV NPV
SST 2 h 85% (69 ⁄ 81) 100% (205 ⁄ 205) 100 94
SST 4 h 93% (75 ⁄ 81) 100% (205 ⁄ 205) 100 97
SST o ⁄n 98% (79 ⁄ 81) 100% (205 ⁄ 205) 100 99
SDT 2 h 68% (55 ⁄ 81) 100% (205 ⁄ 205) 100 89
SDT 4 h 96% (78 ⁄ 81) 100% (205 ⁄ 205) 100 99
SDT o ⁄n 100% (81 ⁄ 81) 100% (205 ⁄ 205) 100 100
aRead after incubation at 37C for 2 h and 4 h, or after overnight (o ⁄n) incubation at
room temperature.
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end. The clinical impact of blood culture results
was limited, in part because treatment was
already targeted on the basis of the micro-
biology results for the primary source of infection
in 12 patients (patients 17–28). This illustrates
the importance of collecting material from
clinically suspect sources of infection and
the importance of rapid microbiology results
obtained with materials other than blood. The
clinical impact of the DTCT may have been
different in those patients who were excluded
from this study.
The contribution of rapid identiﬁcation of
S. aureus from blood culture to antimicrobial
management has not been investigated previ-
ously, except in two studies that showed treat-
ment modiﬁcations in 25% and 38% of patients,
respectively, with combined rapid identiﬁcation
and detection of the mecA gene [14,19]. In the
present setting, in which the prevalence of meth-
icillin-resistant S. aureus was low, the DTCT
contributed to antimicrobial management in
30% of the patients with S. aureus bacteraemia.
Rapid identiﬁcation of S. aureus, combined with
detection of methicillin resistance by molecular
methods, would further impact on patient man-
agement in areas with high frequencies of meth-
icillin-resistant S. aureus. However, even without
the detection of methicillin resistance, the mere
identiﬁcation of S. aureus from blood culture,
together with the clinical presentation, would
prompt the clinician to start treatment and would
allow the cessation of empirical antibiotics pre-
scribed for possible Gram-negative pathogens in
most patients. Until molecular methods become
widely available and fully integrated in the rou-
tine clinical microbiology laboratory, the DTCT
remains a valuable additional test on the basis
Table 2. Clinical diagnosis, antimicrobial treatment and treatment modiﬁcations based on microbiology results in 32
patients with Staphylococcus aureus bacteraemia
Patient Diagnosis
Antimicrobial therapy before BC results Antimicrobial therapy after BC results
Empirical or based on microbiology
results from primary source of infection Drugs Drugs Based on BC result
1 Endocarditis native valve Empirical CRO FCX Gram’s stain
2 CABSI Empirical CRO FCX plus CROa Gram’s stain
3 Endocarditis prosthetic valve Empirical CRO FCX plus RIF Gram’s stain
4 Phlebitis Empirical AMC plus GEN FCX Gram’s stain
5 Phlebitis Empirical AMC FCX DTCT
6 CABSI Empirical TEC plus CAZ FCX DTCT
7 Phlebitis Empirical AMC plus GEN FCX DTCT
8 Phlebitis Empirical TEC plus CIP FCX plus RIF DTCT
9 Bacteraemia Empirical AMC FCX DTCT
10 Phlebitis Empirical TZP FCX DTCT
11 CABSI Empirical AMC plus GEN FCX Deﬁnite identiﬁcation
12 Pneumonia and burn infection Empirical FCX plus CAZ FCX DTCT
13 CABSI and ⁄ or phlebitis Empirical AMC plus GEN AMC plus GENa
14 Infection of fracture ﬁxation device Empirical FCX plus CAZ FCX plus CAZb
15 CABSI Empirical TEC plus CAZ FCX SL, previous BC, culture
16 Phlebitis Empirical TZP FCX SL, previous BC, Gram’s stain
17 Pneumonia Startc, sputum, Gram’s stain FCX FCX
18 Phlebitis Start, catheter tip, culture FCX FCX
19 Infection of hip prosthesis Start, pus, Gram’s stain FCX plus GEN FCX plus GEN
20 Pneumonia Addd, sputum, Gram’s stain FCX plus CIP FCX SL, previous BC, culture
21 Urosepsis Add, urine, culture FCX plus CAZ FCX DTCT
22 Urosepsis with NSC Add, urine, Gram’s stain FCX plus CAZ FCX plus CAZa
23 Infection of VPD SL, VPD, culture FCX FCX
24 Infection of vascular prosthesis SL, pus, culture AMC AMCb
25 Pneumonia SL, sputum, culture FCX FCX
26 Urosepsis with NSC SL, urine, culture FCX FCX
27 Peri-renal abscess SL, pus, culture AMC AMCb
28 Pulmonary abscess SL, sputum, culture AMC AMCb
29 E´ndocarditis of native valve None FCX Gram’s stain
30 Bacteraemia None FCX DTCT
31 Bacteraemia None FCX Gram’s stain
32 Cellulitis None Nonee
BC, blood culture; CABSI, catheter-related bloodstream infection; VPD, ventriculo-peritoneal drain; NSC, nephrostomy catheter; DTCT; direct tube coagulase test; AMC,
amoxycillin–clavulanic acid; CAZ, ceftazidime; CIP, ciproﬂoxacin; CRO, ceftriaxone; FCX, ﬂucloxacillin; GEN, gentamicin; RIF, rifampicin; TEC, teicoplanin, TZP, piperacillin–
tazobactam; SL, empirical therapy streamlined.
aTreatment continued despite blood culture results.
bPolymicrobial infection.
cStart, initiation of anti-staphylococcal therapy.
dAdd, initiation of anti-staphylococcal therapy in addition to already started empirical therapy.
eDied.
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of its good performance, its contribution to
antimicrobial management, its low cost and its
technical simplicity.
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